Assembly Biosciences Inc (ASMB)
16.26
-0.63
(-3.73%)
USD |
NASDAQ |
Nov 04, 16:00
16.30
+0.04
(+0.25%)
After-Hours: 20:00
Assembly Biosciences Enterprise Value: -2.042M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | -2.042M |
| October 31, 2024 | -2.550M |
| October 30, 2024 | -1.217M |
| October 29, 2024 | 3.162M |
| October 28, 2024 | -2.613M |
| October 25, 2024 | -1.915M |
| October 24, 2024 | -1.788M |
| October 23, 2024 | -3.882M |
| October 22, 2024 | -2.676M |
| October 21, 2024 | -3.946M |
| October 18, 2024 | 6.525M |
| October 17, 2024 | 5.636M |
| October 16, 2024 | 2.400M |
| October 15, 2024 | 8.302M |
| October 14, 2024 | -1.280M |
| October 11, 2024 | 1.575M |
| October 10, 2024 | -7.372M |
| October 09, 2024 | -7.689M |
| October 08, 2024 | -17.72M |
| October 07, 2024 | -15.81M |
| October 04, 2024 | -14.67M |
| October 03, 2024 | -16.00M |
| October 02, 2024 | -16.26M |
| October 01, 2024 | -15.37M |
| September 30, 2024 | -13.15M |
| Date | Value |
|---|---|
| September 27, 2024 | -9.022M |
| September 26, 2024 | -10.54M |
| September 25, 2024 | -11.88M |
| September 24, 2024 | -13.08M |
| September 23, 2024 | -6.040M |
| September 20, 2024 | 14.08M |
| September 19, 2024 | 8.175M |
| September 18, 2024 | 6.081M |
| September 17, 2024 | 6.208M |
| September 16, 2024 | 7.223M |
| September 13, 2024 | 5.446M |
| September 12, 2024 | 5.256M |
| September 11, 2024 | 1.068M |
| September 10, 2024 | -2.930M |
| September 09, 2024 | -3.882M |
| September 06, 2024 | -1.407M |
| September 05, 2024 | -4.786M |
| September 04, 2024 | -3.882M |
| September 03, 2024 | -8.768M |
| August 30, 2024 | -6.040M |
| August 29, 2024 | -7.118M |
| August 28, 2024 | -2.994M |
| August 27, 2024 | -6.040M |
| August 26, 2024 | -8.641M |
| August 23, 2024 | -16.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.96M
Minimum
Dec 03 2021
660.41M
Maximum
Jul 20 2020
48.97M
Average
-20.93M
Median
Enterprise Value Benchmarks
| ADMA Biologics Inc | 4.558B |
| Sensus Healthcare Inc | 88.70M |
| Protagonist Therapeutics Inc | 2.190B |
| Precision BioSciences Inc | -35.83M |
| Entrada Therapeutics Inc | 184.97M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.15M |
| Revenue (Quarterly) | 8.533M |
| Total Expenses (Quarterly) | 20.74M |
| EPS Diluted (Quarterly) | -1.98 |
| Profit Margin (Quarterly) | -130.7% |
| Earnings Yield | -52.88% |
| Normalized Earnings Yield | -52.88 |